Chumakov Center hopes to receive license for use of CoviVac vaccine in children in 2022

Russia’s Chumakov Federal Scientific Center for the Research and Development of Immune and Biological Products of the Russian Academy of Sciences hopes to receive a license for the use of its CoviVac coronavirus vaccine in children in 2022

Related Keywords

Moscow ,Moskva ,Russia ,Chumakov ,Stavropol Skiy Kray ,Petersburg ,Sankt Peterburg ,Samara ,Samarskaya Oblast ,Russian ,Aidar Ishmukhametov ,Russia Chumakov Federal Scientific Center ,Chumakov Federal Scientific Center ,Products Of The Russian Academy Sciences ,Biological Products ,Russian Academy ,